The Ozempic Effect: How GLP-1 Drugs Are Reshaping Retail Stocks
Millions are losing weight on GLP-1s and refreshing their wardrobes. Wall Street is only beginning to price what this means for retail stocks.
Millions are losing weight on GLP-1s and refreshing their wardrobes. Wall Street is only beginning to price what this means for retail stocks.
With Treasury yields at 4.3% and stocks trading at 21x earnings, the equity risk premium has compressed to near zero. Here’s what that means.
S&P 500 mega-cap concentration is backfiring in 2026. Equal-weight ETFs like RSP are quietly outperforming. Here’s what that means for investors.
Delta, Carnival, and European airlines jumped as much as 7% on the Iran ceasefire. Here’s why travel stocks lead geopolitical relief rallies — and what risks remain.
Morgan Stanley and Fundstrat are calling for surprise beats as Q1 2026 earnings season kicks off. Here’s why analysts think the chaos may actually help.
Goldman Sachs has completed its Innovator Capital acquisition, pushing its ETF platform to $90 billion. Here’s what it means for the asset management industry.
SK Hynix surged 15%, TSMC 4.8%, Tokyo Electron 10% on ceasefire news. The hidden driver: Iran had been strangling the chip industry’s helium supply.
Wall Street traders have a new acronym for Trump’s pattern of dramatic threats followed by sudden retreats — and it’s reshaping how markets price geopolitical risk in 2026.
Crypto markets are at an inflection point as macro headwinds and institutional flows collide. Here’s what the data shows about where the next move might…
AI adoption is accelerating across industries, reshaping valuations and competitive moats. Here’s what the latest data reveals about market leaders and …